Format

Send to

Choose Destination
Kidney Int. 2007 Oct;72(8):909-11.

Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials.

Author information

1
Division of Nephrology, Saint Louis University, Saint Louis, Missouri 63110, USA. zalaly@slu.edu

Abstract

Vitamin D has been used in the context of secondary hyperparathyroidism in patients with end-stage renal disease. A wave of recent studies suggests that vitamin D treatment may be associated with decreased mortality risk in these patients. The article by Wolf et al. further supports these studies by identifying vitamin D deficiency as a risk factor for early mortality in incident hemodialysis patients.

PMID:
17914416
DOI:
10.1038/sj.ki.5002544
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center